诺迪康品牌怎么样 申请店铺

我要投票 诺迪康在中草药行业中的票数:661 更新时间:2025-07-26
诺迪康是哪个国家的品牌?「诺迪康」是 西藏诺迪康药业股份有限公司 旗下著名品牌。该品牌发源于西藏,由创始人陈达彬在1999-07-14期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力诺迪康品牌出海!将品牌入驻外推网,定制诺迪康品牌推广信息,可以显著提高诺迪康产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

诺迪康怎么样

西藏诺迪康药业股份有限公司是西藏雪域高原上诞生的第一家高新技术制药上市企业,于1999年7月14日创立,1999年7月21日在上海证券交易所上网交易,股票名称:西藏药业,股票代码:600211。

在各级领导的关心和支持下,公司已经发展成为一家拥有员工4000余人,总资产8.2亿元的现代化制药企业。公司累计上缴税金2亿余元,发放员工工资、福利2.2亿余元;公司主要产品诺迪康胶囊年销售额逾亿元,公司生物一类新药重组人脑利钠肽也已经上市销售。

公司拥有西藏诺迪康医药有限公司、成都诺迪康生物制药有限公司、四川诺迪康威光制药有限公司、西藏康达药业有限公司、西藏诺迪康藏药材开发有限公司、四川本草堂药业有限公司等下属子公司。

公司秉承“科学成就健康,健康成就未来”的理念,以科技兴业。在为藏药现代化不遗余力的同时,公司注巨资于生物制品和传统药品的研发,并构建了林芝种植基地和四个生产基地及覆盖全国的营销网络。产品涵盖生物制品、藏药和中药、化学药的产品系列,奠定了西藏药业持续发展的基础,其中具有自主知识产权的生物制品一类新药新活素,代表着目前国际急性心衰急救治疗药物的最高水平,填补了该领域的国内空白。

公司上市以来连续被西藏自治区认定为高新技术企业、西藏自治区农牧业龙头企业,2001年被国家科学技术部认定为国家火炬计划重点高新技术企业。2008年公司被科技部认定为创新型试点企业。公司图形商标(祥云图)经国家工商总局认定为中国驰名商标,公司产品诺迪康胶囊和十味蒂达胶囊被评为国家中药保护品种,同时,还被国家保密局、科学技术部评为秘密级国家秘密技术。

经过多年来的不懈努力,公司已成为拥有一个国家级企业技术中心、四个符合GMP规范的药品生产基地、一个符合GAP藏药材种植基地及覆盖全国的营销网络,集藏药产品、植物药产品、化学药产品、生物制品研发、生产和销售一体的现代化企业。

Tibet nordikang Pharmaceutical Co., Ltd. is the first high-tech pharmaceutical listed enterprise born on the snow capped plateau of Tibet. It was founded on July 14, 1999 and traded on the Internet at Shanghai Stock Exchange on July 21, 1999. Its stock name is Tibet pharmaceutical, and its stock code is 600211. With the concern and support of leaders at all levels, the company has developed into a modern pharmaceutical enterprise with more than 4000 employees and total assets of 820 million yuan. The company has paid taxes of more than 200 million yuan and paid employees salaries and welfare of more than 220 million yuan; the annual sales volume of the company's main product, nordicon capsule, is more than 100 million yuan, and the company's new biological class I recombinant human brain natriuretic peptide has also been listed for sale. The company has subsidiaries including Tibet nordikang Pharmaceutical Co., Ltd., Chengdu nordikang biopharmaceutical Co., Ltd., Sichuan nordikang Weiguang Pharmaceutical Co., Ltd., Tibet Kangda Pharmaceutical Co., Ltd., Tibet nordikang Tibetan Medicine Development Co., Ltd., Sichuan bencaotang Pharmaceutical Co., Ltd. The company adheres to the concept of "science makes health, health makes future", and prospers with science and technology. While sparing no effort for the modernization of Tibetan medicine, the company has invested heavily in the research and development of biological products and traditional drugs, and has built the Linzhi planting base, four production bases and a nationwide marketing network. The products range from biological products, Tibetan medicine, traditional Chinese medicine and chemical medicine, laying the foundation for the sustainable development of Tibetan pharmaceutical industry, among which the biological products with independent intellectual property rights represent the highest level of international emergency treatment drugs for acute heart failure, and fill the domestic gap in this field. Since its listing, the company has been successively recognized as a high-tech enterprise in Tibet Autonomous Region, a leading enterprise in agriculture and animal husbandry in Tibet Autonomous Region, and a key high-tech enterprise in the national torch plan by the Ministry of science and technology of the people's Republic of China in 2001. In 2008, the company was recognized as an innovative pilot enterprise by the Ministry of science and technology. The company's graphic trademark (xiangyuntu) has been recognized as a well-known trademark in China by the State Administration of industry and commerce. The company's products, nordikang capsule and Shiweidida capsule, have been rated as the national traditional Chinese medicine protected varieties. Meanwhile, they have also been rated as the secret level national secret technology by the State Security Bureau and the Ministry of science and technology. After years of unremitting efforts, the company has become a modern enterprise with a national enterprise technology center, four GMP compliant pharmaceutical production bases, a gap compliant Tibetan medicine planting base and a nationwide marketing network, which integrates the research and development, production and sales of Tibetan medicine products, botanical medicine products, chemical medicine products and biological products.

本文链接: https://brand.waitui.com/0b45a7af1.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

佛山顺德昨日新增报告基孔肯雅热确诊病例273例 均为轻症

据“健康顺德”微信公号,佛山市顺德区卫生健康局7月26日发布情况通报:2025年7月25日,我区新增报告基孔肯雅热确诊病例273例,主要分布在乐从镇、北滘镇、陈村镇,均为轻症病例。(财联社)

2小时前

美国加州监管机构:特斯拉未获准提供自动驾驶载客服务

美国加州公用事业委员会当地时间25日证实,特斯拉公司尚未申请必要的许可证来运营自动驾驶汽车。这一决定实质上叫停了特斯拉最早于本周末在加州湾区大范围推出的自动驾驶出租车服务。加州公用事业委员会表示,特斯拉公司还没有得到该机构的批准来向客户提供自动驾驶载客服务,无论是否付费以及车内是否有人类驾驶员。这意味着特斯拉无法在加州测试或运营自动驾驶载客服务,现有许可仅支持传统出租车模式。 (财联社)

2小时前

合合信息AI鉴伪技术亮相2025WAIC,精准拦截规模化AI伪造攻击

36氪获悉,2025世界人工智能大会上,合合信息展示了AI鉴伪技术在人脸视频、AIGC生成图像、证件票据等当今AI伪造“重灾区”中的应用体验。站在屏幕前扫描面部,系统就会实时生成一个“数字假面”,当真假人脸同屏对比时,AI伪造面容近乎完美地复刻了真实人脸的表情纹路。据合合信息技术团队人员介绍,展会互动装置中实时生成的“假脸”由当前主流伪造算法生成,在合合信息AI人脸鉴伪模型的解析下,一张张“假脸”可被精准挑出。

2小时前

XREAL亮相WAIC 2025,首次面向公众开放AR+AI主题体验空间

36氪获悉,7月26日,世界人工智能大会(WAIC 2025)上,XREAL重点展出了最新旗舰产品 XREAL One Pro,还首次面向公众开放了AR+AI主题体验空间,该空间基于XREAL自主研发的6DoF空间定位技术,融合AI大模型,能够实时呈现高精度的三维虚拟内容,实现数字世界与现实场景的无缝融合。据悉,7月28日,XREAL One Pro在WAIC期间同步开启中国市场发售。

2小时前

网易多款AI应用首次亮相人工智能大会,发布具身智能模型“灵掘”

36氪获悉,7月26日,网易在世界人工智能大会上首次展示工程机械、教育领域多款AI新品。网易旗下的网易灵动发布了全球首个专为露天矿山挖掘机装车场景打造的具身智能模型“灵掘”,并展示全球首个“端到端”工程机械大模型真实部署案例。目前,“灵掘”已在内蒙古露天矿山投入实地运营,现场观众可以在展位通过智能挖掘机座舱,体验来自1000多公里外的无人挖掘机自动装车功能。此外,“灵掘”还将首次开放其数据集与模型方案,推动行业技术共享。

2小时前

本页详细列出关于诺迪康的品牌信息,含品牌所属公司介绍,诺迪康所处行业的品牌地位及优势。
咨询